[EN] MUTANT PI3K-ALPHA INHIBITORS AND THEIR USE AS PHARMACEUTICALS [FR] INHIBITEURS DE PI3K-ALPHA MUTANTS ET LEUR UTILISATION EN TANT QUE PRODUITS PHARMACEUTIQUES
摘要:
The disclosure is directed to compounds of Formula I (I) Pharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.
Described herein are compounds of Formula (I) and tautomers and pharmaceutical salts thereof, compositions and formulations containing such compounds, and methods of using and making such compounds.
Described herein are compounds of Formula (I) and tautomers and pharmaceutical salts thereof, compositions and formulations containing such compounds, and methods of using and making such compounds.
[EN] KAPPA OPIOID RECEPTOR ANTAGONISTS AND PRODUCTS AND METHODS RELATED THERETO<br/>[FR] ANTAGONISTES DU RÉCEPTEUR OPIOÏDE KAPPA ET PRODUITS ET PROCÉDÉS ASSOCIÉS
申请人:SCRIPPS RESEARCH INST
公开号:WO2018170492A9
公开(公告)日:2018-12-13
QUINAZOLINE DERIVATIVES USED TO TREAT HIV
申请人:Gilead Sciences, Inc.
公开号:EP3237398B1
公开(公告)日:2018-12-19
Quinazoline Compounds
申请人:Gilead Sciences, Inc.
公开号:US20170354656A1
公开(公告)日:2017-12-14
Described herein are compounds of Formula (I) and tautomers and pharmaceutical salts thereof, compositions and formulations containing such compounds, and methods of using and making such compounds.